Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesPharmacy & Specialty Drugsmedimpact tretinoin Prior Auth Policy Update | Ope…
    Ask Trek AI about this page
    ModifiedmedimpactPolicy N/A

    Tretinoin prior authorization criteria (Kentucky Medicaid)

    Customize your policy alerts

    Sign up for all medimpact policy alerts

    Know when medimpact releases new policies or updates existing guidance.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    Defines new prior authorization clinical criteria for tretinoin formulations for Kentucky Medicaid (Fee-for-Service and MCO) effective June 1, 2026; affects pharmacy providers, prescribers, and beneficiaries covered by Kentucky Medicaid.

    Policy Summary
    Payermedimpact
    PolicyTretinoin prior authorization criteria (Kentucky Medicaid)
    Policy CodePolicy N/A
    Change TypeNew prior authorization criteria
    Effective Date06/01/2026
    Next Review DateN/A
    Key ActionObtain prior authorization for listed tretinoin products and ensure prescriber attestation that use is not solely for cosmetic purposes.
    SourceLink
    POLICY UPDATE CHANGES

    Tretinoin cream, tretinoin microsphere gel, and clindamycin/tretinoin gel are subject to prior authorization beginning 06/01/2026.

    Approval duration set to 1 year when criteria met.

    Clinical criteria require diagnosis of acne vulgaris and prescriber attestation that the medication is not being used solely for cosmetic purposes.

    06/01/2026effective date
    1 yrapproval duration
    3agents subject
    KY Medicaidaffected program

    Coverage Criteria

    Initial authorization

    Covered when ALL of the following are met:

    Initial authorization: Diagnosis of acne vulgaris
    Initial authorization: Prescriber attestation that the medication is not being used solely for cosmetic purposes (e.g., photoaging, wrinkling, hyperpigmentation, melasma, roughness of skin, or sun damage)
    Initial authorization: Requested product is one of: tretinoin cream; tretinoin microsphere gel (gel pump); clindamycin/tretinoin gel

    Approval duration: 1 year when criteria are met.

    Use solely for cosmetic purposes is excluded from coverage under these criteria. Examples of cosmetic indications that are not covered include photoaging, wrinkling, hyperpigmentation, melasma, roughness of skin, or sun damage.

    Policy Summary
    Payermedimpact
    PolicyTretinoin prior authorization criteria (Kentucky Medicaid)
    Policy CodePolicy N/A
    Change TypeNew prior authorization criteria
    Effective Date06/01/2026
    Next Review DateN/A
    Key ActionObtain prior authorization for listed tretinoin products and ensure prescriber attestation that use is not solely for cosmetic purposes.
    SourceLink
    On This Page
    Coverage CriteriaAffected Products & CodingProvider Actions & Prior AuthorizationDefinitionsInitial Therapy CriteriaContinuation / Renewal CriteriaBackground

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    As part of the approval requirements, the prescriber must attest that the tretinoin product is not being used solely for cosmetic purposes. Requests where the prescriber attests the medication is being used solely for cosmetic indications will not meet medical necessity and therefore will not satisfy the criteria for prior authorization.

    Affected Products & Coding

    Affected drug products (by name)mixed
    tretinoin creamtretinoin cream
    tretinoin microsphere gel (gel pump)tretinoin microsphere gel (gel pump)
    clindamycin/tretinoin gelclindamycin/tretinoin gel
    not specifiedNo specific NDC, HCPCS, or CPT codes were listed in the document; agents were identified by name/description.
    inv-05: Approval duration — 1 year
    Approval duration1 year
    Effective date for duration06/01/2026
    Applies when criteria metApproval duration of 1 year granted when diagnosis of acne vulgaris and prescriber attestation that use is not solely cosmetic are documented

    Provider Actions & Prior Authorization

    Prior Authorization

    Prior authorization required for specified tretinoin products

    Prior authorization is required for tretinoin cream, tretinoin microsphere gel (gel pump), and clindamycin/tretinoin gel for Kentucky Medicaid effective 06/01/2026; approvals are granted for 1 year when criteria are met. Pharmacy providers should work with prescribers and patients to obtain PA or consider alternatives as appropriate.

    • Effective date: 06/01/2026
    • Agents: tretinoin cream; tretinoin microsphere gel (gel pump); clindamycin/tretinoin gel
    • Approval duration when criteria met: 1 year
    Note

    Provider resources and contacts

    Pharmacy providers are encouraged to reference the Kentucky Medicaid PDL and Prior Authorization documents on the MedImpact Provider Portal and to contact the Kentucky MedImpact team for Fee-for-Service or MCO questions.

    • Provider portal: https://kyportal.medimpact.com/provider-documents/drug-information
    • Fee-for-Service contact: KYMFFS@medimpact.com
    • MCO contact: KYMCOPBM@medimpact.com
    Documentation Required

    Required prescriber attestation regarding non-cosmetic use

    The prescriber must attest that the tretinoin product is not being used solely for cosmetic purposes; examples of cosmetic uses are listed in the policy and must be considered when attesting.

    • Examples of cosmetic purposes: photoaging, wrinkling, hyperpigmentation, melasma, roughness of skin, or sun damage
    Denial Risk

    Criteria-based denials for missing diagnosis or attestation

    Requests will be denied if the approval criteria are not met — specifically when there is no diagnosis of acne vulgaris or when the prescriber attestation that the medication is not being used solely for cosmetic purposes is missing.

    • Denial triggers: absence of an acne vulgaris diagnosis; missing prescriber attestation of non-cosmetic use

    Definitions

    inv-11: Cosmetic purposes — examples
    PhotoagingListed as an example of cosmetic purpose excluded from medical necessity
    WrinklingListed as an example of cosmetic purpose excluded from medical necessity
    Hyperpigmentation / MelasmaListed as examples of cosmetic purposes (hyperpigmentation, melasma) excluded from medical necessity
    Roughness of skinListed as an example of cosmetic purpose excluded from medical necessity
    Sun damageListed as an example of cosmetic purpose excluded from medical necessity

    Initial Therapy Criteria

    Initial therapy

    Initial authorization

    Initial: Requested product is one of the listed tretinoin agents (tretinoin cream; tretinoin microsphere gel, gel pump; clindamycin/tretinoin gel)

    Approval duration: 1 year when criteria are met.

    Initial: Diagnosis of acne vulgaris
    Initial: Prescriber attestation that the medication is not being used solely for cosmetic purposes (examples: photoaging, wrinkling, hyperpigmentation, melasma, roughness of skin, or sun damage)

    Continuation / Renewal Criteria

    Renewal criteria

    Continuation/renewal

    Renewal approvals are granted for 1 year when the initial criteria continue to be met (ongoing diagnosis of acne vulgaris and prescriber attestation that use is not solely cosmetic)

    Background

    Tretinoin products are topical retinoids commonly used to treat acne vulgaris. This policy implements prior authorization for specified tretinoin formulations for Kentucky Medicaid effective 06/01/2026. The agents subject to the criteria are tretinoin cream, tretinoin microsphere gel (gel pump), and clindamycin/tretinoin gel. When the clinical criteria are met — a diagnosis of acne vulgaris and prescriber attestation that the product is not being used solely for cosmetic purposes — approvals are granted for 1 year.